Prevention of hospital-acquired pneumonia with Yupingfeng Powder in patients with acute cerebral vascular diseases: a randomized controlled trial / 中西医结合学报
Journal of Integrative Medicine
; (12): 25-9, 2010.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-448894
Responsible library:
WPRO
ABSTRACT
An increase in the incidence rate of hospital-acquired pneumonia (HAP) has a direct influence on prognosis and survival of patients with acute cerebral vascular diseases (ACVD), and how to prevent HAP is a growing concern to clinicians.
Full text:
Available
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Goal 10: Communicable diseases
/
Pneumonia
Database:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Journal of Integrative Medicine
Year:
2010
Document type:
Article